117 related articles for article (PubMed ID: 2980246)
1. Neuroendocrine lung structures and tumours: immunohistochemical study by specific markers.
Mosca L; Barbareschi M; Mauri MF; Munguia-Barrera J; Frigo B; Muscarà M; Valentini L; Mariscotti C
Histol Histopathol; 1988 Oct; 3(4):367-76. PubMed ID: 2980246
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.
Gould VE; Linnoila RI; Memoli VA; Warren WH
Lab Invest; 1983 Nov; 49(5):519-37. PubMed ID: 6138458
[TBL] [Abstract][Full Text] [Related]
4. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
5. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
6. S-100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature.
Barbareschi M; Mauri MF; Muscara M; Mauri FA; Lo Re V
Histol Histopathol; 1987 Apr; 2(2):185-92. PubMed ID: 2856552
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
8. Expression of neuroendocrine markers in non-small cell lung cancer.
Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Schürmann G; Betzler M; Buhr HJ
Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
11. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
Poola I; Graziano SL
J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
[TBL] [Abstract][Full Text] [Related]
12. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
Hachitanda Y; Tsuneyoshi M; Enjoji M
Arch Pathol Lab Med; 1989 Apr; 113(4):381-4. PubMed ID: 2495784
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
[TBL] [Abstract][Full Text] [Related]
14. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
15. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
Jiang SX; Kameya T; Shinada J; Yoshimura H
Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
[TBL] [Abstract][Full Text] [Related]
16. Secretagogin is a new neuroendocrine marker in the human prostate.
Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
18. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
Springall DR; Lackie P; Levene MM; Marangos PJ; Polak JM
J Pathol; 1984 Aug; 143(4):259-65. PubMed ID: 6090626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]